GRI · Categories · Form 4

GRI - SEC Form 4 insider transactions

GRI Bio Inc. (GRI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for GRI

• 274d
  SEC Form 4 filed by Chief Financial Officer Kelly Leanne

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 274d
  SEC Form 4 filed by Director Szekeres David Leslie

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 274d
  SEC Form 4 filed by Director Baker David Charles

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 274d
  SEC Form 4 filed by Director Simpson Camilla V

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 274d
  SEC Form 4 filed by Chief Scientific Officer Chaturvedi Vipin

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 274d
  SEC Form 4 filed by Director Rongen Roelof

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 274d
  SEC Form 4 filed by Chief Executive Officer Hertz Walter Marc

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 301d
  SEC Form 4 filed by Chief Executive Officer Hertz Walter Marc

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 301d
  SEC Form 4 filed by Director Szekeres David Leslie

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 301d
  SEC Form 4 filed by Director Baker David Charles

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 301d
  SEC Form 4 filed by Director Rongen Roelof

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 301d
  SEC Form 4 filed by Chief Scientific Officer Chaturvedi Vipin

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 301d
  SEC Form 4 filed by Director Simpson Camilla V

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 301d
  SEC Form 4 filed by Chief Financial Officer Kelly Leanne

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 313d
  SEC Form 4 filed by Director Simpson Camilla V

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 313d
  SEC Form 4 filed by Director Baker David Charles

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 313d
  SEC Form 4 filed by Director Szekeres David Leslie

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 313d
  SEC Form 4 filed by Director Rongen Roelof

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 515d
  SEC Form 4 filed by Chief Financial Officer Kelly Leanne

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 515d
  SEC Form 4 filed by Chief Scientific Officer Chaturvedi Vipin

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 515d
  SEC Form 4 filed by Chief Executive Officer Hertz Walter Marc

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 515d
  SEC Form 4 filed by Director Simpson Camilla V

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 515d
  SEC Form 4 filed by Director Baker David Charles

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 515d
  SEC Form 4 filed by Director Szekeres David Leslie

  4 - GRI Bio, Inc. (0001824293) (Issuer)
• 515d
  SEC Form 4 filed by Director Rongen Roelof

  4 - GRI Bio, Inc. (0001824293) (Issuer)

Other GRI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends